beyond glp-1 insulin: The Intriguing role of in Parkinson's disease Frontiers | Beyond GLP-1: underexplored
Description
Starting with a lower dose and gradually increasing it can help minimise these effects
This additional mechanism appears to contribute to tirzepatides superior efficacy in clinical trials
Burcelin et al., 1999)
)
Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention
Spending money on an unproven supplement delays access to treatments that are proven to work
doi: 10.1001/jamapsychiatry.2022.4101, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] Singh S., Botvinnik A., Shahar O., Wolf G., Yakobi C., Saban M., et al
